Felix Baldauf-Lenschen is the CEO and Founder of Altis Labs, a computational imaging company that helps leading pharmaceutical companies transform drug development with AI.

Felix believes that the greatest potential for AI isn’t in automating human tasks but in generating net new knowledge that helps us push the boundaries of scientific understanding. To that end, his team at Altis has built the world’s largest and most comprehensive cancer imaging database with associated clinical information to train prognostic deep learning models.

Companies like AstraZeneca and Bayer Pharmaceuticals harness these models to enable smaller, faster, and more successful clinical trials so that patients benefit from the best treatments sooner. Felix’s work has been published in the Journal of Clinical Oncology and at the American Society of Clinical Oncology.